Number of the records: 1  

Cockayneov syndróm

  1. SYSd003057
    LBL
      
    00000cz--a2200000o--4500
    005
      
    20250606213407.1
    008
      
    920509|||anznnbabn-----------|-a|a------
    040
      
    $b slo $a DNLM $d BA006
    065
      
    $a C05.116.099.343.250
    065
      
    $a C10.574.500.362
    065
      
    $a C16.131.077.250
    065
      
    $a C16.320.240.562
    065
      
    $a C16.320.400.200
    065
      
    $a C18.452.284.250
    066
      
    $a 01 $c 03
    150
      
    $a Cockayneov syndróm $x BL $x CF $x CI $x CL $x CO $x DG $x DH $x DI $x DT $x EC $x EH $x EM $x EN $x EP $x ET $x GE $x HI $x IM $x ME $x MI $x MO $x NU $x PA $x PC $x PP $x PS $x PX $x RH $x RT $x SU $x TH $x UR $x VE $x VI $2 slo
    450
      
    $w v $a Progeria-Like Syndrome $2 eng
    450
      
    $w v $a nanismus progeroides $2 slo
    450
      
    $w v $a syndróm progeroidný $2 slo
    550
      
    $7 sllk_us_auth*d008607 $Y Intellectual Disability $w p $a postihnutie intelektuálne
    550
      
    $7 sllk_us_auth*d011371 $Y Progeria $w b $a progéria
    665
      
    $a 1991(1981); use DWARFISM 1981-1990 $2 eng
    665
      
    $a Dwarfism (1966-1980) $2 eng
    665
      
    $a Photosensitivity Disorders (1966-1980) $2 eng
    680
    9-
    $i A syndrome characterized by multiple system abnormalities including DWARFISM; PHOTOSENSITIVITY DISORDERS; PREMATURE AGING; and HEARING LOSS. It is caused by mutations of a number of autosomal recessive genes encoding proteins that involve transcriptional-coupled DNA REPAIR processes. Cockayne syndrome is classified by the severity and age of onset. Type I (classical; CSA) is early childhood onset in the second year of life; type II (congenital; CSB) is early onset at birth with severe symptoms; type III (xeroderma pigmentosum; XP) is late childhood onset with mild symptoms. $2 eng
    750
    -2
    $a Cockayne Syndrome $2 eng
    980
      
    $x M
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.